博济医药 (300404.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(博济医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 126,422,508.85129,060,414.07103,299,782.23145,254,020.57103,364,118.12100,880,183.0674,184,304.67
 营业收入(元) 126,422,508.85129,060,414.07103,299,782.23145,254,020.57103,364,118.12100,880,183.0674,184,304.67
二、营业总成本(元) 124,024,644.33127,196,592.0995,145,102.03131,607,442.3798,885,517.1098,932,926.8269,042,568.57
 营业成本(元) 81,666,951.0284,979,959.8962,805,195.5592,871,475.7064,613,673.4663,601,897.3941,883,178.91
 研发费用(元) 13,084,398.4013,469,797.979,986,450.8214,052,955.5010,901,925.8310,207,961.948,513,725.40
 营业税金及附加(元) 1,233,862.381,130,952.931,013,159.371,163,809.341,105,056.24899,703.94863,705.18
 销售费用(元) 12,715,433.0911,013,184.927,095,599.838,347,784.948,064,696.378,918,629.775,764,868.38
 管理费用(元) 15,284,244.5216,869,432.9814,539,602.9815,433,539.3914,413,975.7815,559,059.9812,149,462.23
 财务费用(元) 39,754.92-266,736.60-294,906.52-262,122.50-213,810.58-254,326.20-132,371.53
  其中:利息费用(元) 457,052.77392,405.11244,995.48166,682.93104,906.26153,326.33279,376.70
  其中:利息收入(元) 451,465.18690,211.95606,825.47454,012.24344,475.79428,200.06451,084.77
 资产减值损失(元) -1,083,619.25-1,285,535.8410,218.68-7,771,385.46-998,685.16-1,973,611.21221,566.45
 信用减值损失(元) -1,556,671.94-2,458,079.54-1,973,757.33-4,570,255.49-2,030,806.25-1,208,226.10-1,500,243.03
三、其他经营收益
 加:公允价值变动收益(元) 336,692.9555,853.60149,609.28164,889.49705,579.45112,414.16808,198.47
 加:投资收益(元) 384,825.09479,800.33125,710.20286,967.99132,085.201,140,030.18403,361.65
  其中:对联营企业和合营企业的投资收益(元) -33,219.77-25,303.94-32,616.54-26,011.07-14,728.48-6,839.99251.46
 其他收益(元) 1,485,678.693,568,546.516,365,552.972,136,160.601,707,806.201,759,850.934,796,122.35
四、营业利润(元) 1,965,702.022,224,407.0412,832,014.003,892,955.333,994,580.461,777,714.209,870,741.99
 加:营业外收入(元) 118,580.262.3820,094.900.3640,808.36138,101.425,000,009.62
 减:营业外支出(元) 20,202.4264.3113,860.84128,763.29780.0310,788.392,294.30
五、利润总额(元) 2,064,079.862,224,345.1112,838,248.063,764,192.404,034,608.791,905,027.2314,868,457.31
 减:所得税费用(元) -4,125,307.25-4,088,635.54493,436.51-3,174,173.77-2,644,744.96-830,686.581,909,459.66
六、净利润(元) 6,189,387.116,312,980.6512,344,811.556,938,366.176,679,353.752,735,713.8112,958,997.65
(一)按经营持续性分类
  持续经营净利润(元) 6,189,387.116,312,980.6512,344,811.556,938,366.176,679,353.752,735,713.8112,958,997.65
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 5,403,577.085,880,523.7011,738,526.836,281,162.826,511,452.332,415,053.2212,461,872.32
  少数股东损益(元) 785,810.03432,456.95606,284.72657,203.35167,901.42320,660.59497,125.33
 扣除非经常性损益后的净利润(元) 3,930,576.102,587,948.507,129,018.834,768,359.274,660,922.91213,581.423,579,114.49
七、每股收益
 一、基本每股收益(元) 0.010.020.030.020.02-0.010.05
 二、稀释每股收益(元) 0.010.020.030.020.02-0.010.05
八、其他综合收益(元) -518,244.362,176,601.22-534,887.84-688,264.092,263,749.791,974,704.65-140,223.89
 归属于母公司股东的其他综合收益(元) -492,332.142,067,771.16-508,143.45-653,850.882,150,562.301,875,969.42-133,212.70
 归属于少数股东的其他综合收益(元) -25,912.22108,830.06-26,744.39-34,413.21113,187.4998,735.23-7,011.19
九、综合收益总额(元) 5,671,142.758,489,581.8711,809,923.716,250,102.088,943,103.544,710,418.4612,818,773.76
 归属于母公司所有者的综合收益总额(元) 4,911,244.947,948,294.8611,230,383.385,627,311.948,662,014.634,291,022.6412,328,659.62
 归属于少数股东的综合收益总额(元) 759,897.81541,287.01579,540.33622,790.14281,088.91419,395.82490,114.14
公告日期 2023-10-272023-08-262023-04-262023-04-262022-10-272022-08-262022-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院